HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
108.60
-3.12 (-2.79%)
Feb 21, 2025, 4:00 PM EST - Market closed
HealthEquity Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for HealthEquity stock have an average target of 111.23, with a low estimate of 100 and a high estimate of 130. The average target predicts an increase of 2.42% from the current stock price of 108.60.
Analyst Consensus: Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for HealthEquity stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 8 | 8 | 8 | 9 | 9 | 9 |
Hold | 0 | 0 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 11 | 12 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Maintains $105 → $107 | Buy | Maintains | $105 → $107 | -1.47% | Dec 10, 2024 |
RBC Capital | RBC Capital | Buy Maintains $100 → $105 | Buy | Maintains | $100 → $105 | -3.31% | Dec 10, 2024 |
Mizuho | Mizuho | Buy Initiates $126 | Buy | Initiates | $126 | +16.02% | Dec 4, 2024 |
Barrington Research | Barrington Research | Buy Maintains $105 → $120 | Buy | Maintains | $105 → $120 | +10.50% | Dec 2, 2024 |
Goldman Sachs | Goldman Sachs | Hold Initiates $108 | Hold | Initiates | $108 | -0.55% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
1.21B
from 999.59M
Increased by 20.65%
Revenue Next Year
1.32B
from 1.21B
Increased by 9.04%
EPS This Year
3.18
from 0.64
Increased by 397.58%
EPS Next Year
3.75
from 3.18
Increased by 17.72%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 1.3B | 1.4B | 1.6B | |
Avg | 1.2B | 1.3B | 1.5B | |
Low | 1.2B | 1.3B | 1.4B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 26.1% | 19.8% | 18.8% | |
Avg | 20.6% | 9.0% | 10.9% | |
Low | 16.4% | 4.1% | 3.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 3.32 | 4.18 | 5.03 | |
Avg | 3.18 | 3.75 | 4.54 | |
Low | 3.07 | 3.53 | 4.17 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 418.4% | 31.2% | 34.2% | |
Avg | 397.6% | 17.7% | 21.1% | |
Low | 379.3% | 10.8% | 11.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.